{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:10:12Z","timestamp":1792267812270,"version":"4.4.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annemergmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.annemergmed.2020.11.008","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T04:26:04Z","timestamp":1612931164000},"page":"479-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Between Emergency Department Visits: The Role of Harm Reduction Programs in Mitigating the Harms Associated With Injection Drug Use"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5752-2104","authenticated-orcid":false,"given":"Wendy","family":"Macias-Konstantopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Heins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn J.","family":"Sachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula J.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil-Jeremy G.","family":"Wingkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph J.","family":"Riviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2020.11.008_bib1","doi-asserted-by":"crossref","first-page":"e97596","DOI":"10.1371\/journal.pone.0097596","article-title":"Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C virus infections","volume":"9","author":"Lansky","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib2","series-title":"Wide-Ranging Online\u00a0Data\u00a0for Epidemiologic Research (WONDER): Drug Overdose Deaths","year":"2017"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib3","series-title":"Results From the 2013 National Survey on Drug Use and Health: Summary of National Findings","year":"2014"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2013-2017","volume":"69","author":"Scholl","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/10826084.2016.1271432","article-title":"Heroin and methamphetamine injection: an emerging drug use pattern","volume":"52","author":"Al-Tayyib","year":"2017","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib6","series-title":"Drug\u00a0Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits","year":"2013"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib7","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.annemergmed.2020.06.046","article-title":"Use of amphetamine-type stimulants among emergency department patients with untreated opioid use disorder","volume":"76","author":"Chawarski","year":"2020","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib8","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1016\/S2352-3018(18)30176-0","article-title":"Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011-15: a modelling study","volume":"5","author":"Gonsalves","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib9","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/cid\/ciz321","article-title":"Implementation of syringe services programs to prevent rapid human immunodeficiency virus transmission in rural counties in the United States: a modeling study","volume":"70","author":"Goedel","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib10","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.2105\/AJPH.2019.305268","article-title":"Paraphernalia laws, criminalizing possession and distribution of items used to consume illicit drugs, and injection-related harm","volume":"109","author":"Davis","year":"2019","journal-title":"Am J Public Health"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2018.10.082","article-title":"Clinical outcomes of infective endocarditis in injection drug users","volume":"73","author":"Rudasill","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib12","doi-asserted-by":"crossref","first-page":"ofw157","DOI":"10.1093\/ofid\/ofw157","article-title":"Increasing infectious endocarditis admissions among young people who inject drugs","volume":"3","author":"Wurcell","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jclp.20669","article-title":"Harm reduction therapy: a practice-friendly review of research","volume":"66","author":"Logan","year":"2010","journal-title":"J\u00a0Clin Psychol"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib15","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2105\/AJPH.2009.185652","article-title":"A\u00a0framework for public health action: the health impact pyramid","volume":"100","author":"Frieden","year":"2010","journal-title":"Am J Public Health"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib17","series-title":"Countermeasures That Work","year":"2016"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/sw\/49.3.353","article-title":"Harm reduction: a new perspective on substance abuse services","volume":"49","author":"MacMaster","year":"2004","journal-title":"Soc Work"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0306-4603(96)00042-1","article-title":"Harm reduction: come as you are","volume":"21","author":"Marlatt","year":"1996","journal-title":"Addict Behav"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib21","first-page":"235","article-title":"Reducing fatal opioid overdose: prevention, treatment and harm reduction strategies","volume":"88","author":"Hawk","year":"2015","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib22","first-page":"101","article-title":"Community-based opioid overdose prevention programs providing naloxone\u2014US, 2010","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib23","doi-asserted-by":"crossref","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time-series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib24","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2105\/AJPH.2008.146647","article-title":"Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose","volume":"99","author":"Doe-Simkins","year":"2009","journal-title":"Am J Public Health"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5811\/westjem.2015.2.24909","article-title":"Opioid education and nasal naloxone rescue kits in the emergency department","volume":"16","author":"Dwyer","year":"2015","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.annemergmed.2016.07.027","article-title":"Factors associated with participation in an emergency department\u2013based take-home naloxone\u00a0program for at-risk opioid users","volume":"69","author":"Kestler","year":"2017","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib27","first-page":"38","article-title":"ED naloxone distribution: a Rhode Island department of health, recovery community, and ED partnership to reduce opioid overdose deaths","volume":"97","author":"Samuels","year":"2014","journal-title":"R\u00a0I Med J"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jsat.2018.07.013","article-title":"Peer navigation and take-home naloxone for opioid overdose emergency department patients: preliminary patient outcomes","volume":"94","author":"Samuels","year":"2018","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib31","first-page":"53","article-title":"The epidemiology of HIV infection in Edinburgh related to the injecting of drugs: an historical perspective and new insight regarding the past incidence of HIV infection and derived from retrospective HIV antibody testing of stored samples of serum","volume":"32","author":"Burns","year":"1996","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib32","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.drugpo.2005.02.004","article-title":"Effectiveness of sterile needle and syringe programmes","volume":"16S","author":"Wodak","year":"2005","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12954-019-0327-1","article-title":"I\u00a0could take the judgement if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018","volume":"16","author":"Meyerson","year":"2019","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib36","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drugpo.2014.05.008","article-title":"Syringe disposal among people who inject drugs in Los Angeles: the role of sterile syringe source","volume":"25","author":"Quinn","year":"2014","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib37","series-title":"Guide to Starting and Managing Needle and Syringe Programmes","first-page":"19","year":"2007"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib38","series-title":"Guide to Developing and Managing Syringe Access Programs","first-page":"27","author":"Winkelstein","year":"2010"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib39","first-page":"1137","article-title":"Syringe service programs for persons who inject drugs in urban, suburban, and rural areas\u2014United States, 2013","volume":"64","author":"DesJarlais","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib40","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0140-6736(96)11380-5","article-title":"Effectiveness of needle-exchange programmes for prevention of HIV infection","volume":"349","author":"Hurley","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jama.300.5.520","article-title":"Estimation of HIV incidence in the United States","volume":"300","author":"Hall","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib42","first-page":"1","article-title":"Surveillance for acute viral hepatitis--United States, 2007","volume":"58","author":"Daniels","year":"2009","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib43","series-title":"WHO, UNODC, UNAIDS Technical Guide\u00a0for Countries to Set Targets for Universal Access to HIV Prevention, Treatment and Care for Injecting Drug Users","year":"2009"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A\u00a0systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs","volume":"204","author":"Hagan","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","article-title":"Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness","volume":"25","author":"MacArthur","year":"2014","journal-title":"Int J Drug"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib46","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1007\/s10461-013-0593-y","article-title":"Effectiveness of structural-level needle\/syringe programs to reduce HCV and HIV infection among people who inject drugs: systematic review","volume":"17","author":"Abdul-Quader","year":"2013","journal-title":"AIDS Behav"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12954-017-0156-z","article-title":"Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis","volume":"14","author":"Davis","year":"2017","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib48","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/add.14012","article-title":"Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis","volume":"113","author":"Platt","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib49","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1360-0443.2009.02888.x","article-title":"Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and HIV transmission among injecting drug users: a review of reviews","volume":"105","author":"Palmateer","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2011.12.001","article-title":"A\u00a0comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs","volume":"123","author":"Tookes","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib53","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1176\/appi.ps.201400140","article-title":"Stigma, discrimination, treatment effectiveness, and policy: public views about drug addiction and mental illness","volume":"65","author":"Barry","year":"2014","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib54","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2105\/AJPH.2005.065961","article-title":"Social and political factors\u00a0predicting the presence of syringe exchange programs\u00a0in\u00a096\u00a0US metropolitan areas","volume":"97","author":"Tempalski","year":"2007","journal-title":"Am J Public Health"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugpo.2013.06.005","article-title":"Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: a community-level perspective","volume":"25","author":"Beletsky","year":"2014","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib56","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2105\/AJPH.2015.302681","article-title":"Police encounters among needle exchange clients in Baltimore: drug law enforcement as a structural determinant of health","volume":"105","author":"Beletsky","year":"2015","journal-title":"Am J Public Health"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12954-017-0157-y","article-title":"Two steps forward, one step back: current harm reduction policy and politics in the United States","volume":"14","author":"Nadelmann","year":"2017","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib59","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMc2015435","article-title":"Evaluation of an unsanctioned safe consumption site in the United States","volume":"383","author":"Kral","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib60","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.amepre.2017.06.010","article-title":"Addressing the nation\u2019s opioid epidemic: lessons from an unsanctioned supervised injection site in the US","volume":"53","author":"Kral","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib61","author":"Cohen"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib62","series-title":"Report of the Toronto and Ottawa Supervised Consumption Assessment Study, 2012","author":"Bayoumi","year":"2012"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib63","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1465-3362.2009.00025.x","article-title":"Access to health and social services for IDU: the impact of a medically supervised injection facility","volume":"28","author":"Small","year":"2009","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib64","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1503\/cmaj.060863","article-title":"Summary of findings from the evaluation of a pilot medically supervised safer injecting facility","volume":"175","author":"Wood","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib65","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","article-title":"Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: a retrospective population-based study","volume":"377","author":"Marshall","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib66","doi-asserted-by":"crossref","first-page":"e3351","DOI":"10.1371\/journal.pone.0003351","article-title":"Estimated drug overdose deaths averted by North America\u2019s first medically supervised safer injection facility","volume":"3","author":"Milloy","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib67","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","article-title":"Supervised injection services: what has been demonstrated? a systematic literature review","volume":"145","author":"Potier","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib68","author":"Shaw"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib69","first-page":"35","article-title":"Changes in injecting practices associated with the use of a medically supervised safer injection facility","volume":"29","author":"Stoltz","year":"2007","journal-title":"J\u00a0Public Health"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1477-7517-11-29","article-title":"Self-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen, Denmark","volume":"11","author":"Kinnard","year":"2014","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib71","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.drugalcdep.2011.03.006","article-title":"Potential role of safer injection facilities in reducing HIV and hepatitis C infection and overdose mortality in the United States","volume":"118","author":"Semaan","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib72","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11904-007-0023-8","article-title":"The role of safer injection facilities in the response to HIV\/AIDS among injection drug users","volume":"4","author":"Kerr","year":"2007","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib73","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12954-015-0083-9","article-title":"Risk environments facing potential users of a supervised injection site in Ottawa, Canada","volume":"12","author":"Shaw","year":"2015","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12954-017-0139-0","article-title":"Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study","volume":"14","author":"Bouvier","year":"2017","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib75","first-page":"353","article-title":"Willingness to use safe consumption spaces among opioid users at high risk of fentanyl overdose in Baltimore, Providence, and Boston","volume":"96","author":"Park","year":"2019","journal-title":"J\u00a0Urban Health"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib76","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1056\/NEJMc052939","article-title":"Attendance at supervised injecting facilities and use of detoxification services","volume":"354","author":"Wood","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib77","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugalcdep.2010.07.023","article-title":"Injection drug use cessation and use of North America\u2019s first medically supervised safer injecting facility","volume":"113","author":"Debeck","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib78","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1747-597X-1-13","article-title":"Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime","volume":"1","author":"Wood","year":"2006","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib79","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.socscimed.2008.05.012","article-title":"Seeking refuge from violence in street-based drug scenes: women\u2019s experiences in North America\u2019s first supervised injection facility","volume":"67","author":"Fairbairn","year":"2008","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib80","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1097\/QAI.0000000000000628","article-title":"Women who use or inject drugs: an action\u00a0agenda for women-specific, multilevel and combination HIV prevention and research","volume":"69","author":"El-Bassel","year":"2015","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib81","author":"Jaywork"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib82","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1037\/0003-066X.47.9.1102","article-title":"In search of how people change: applications to addictive behaviors","volume":"47","author":"Prochaska","year":"1992","journal-title":"Am Psychol"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib83","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12954-017-0196-4","article-title":"Harm reduction principles for healthcare settings","volume":"14","author":"Hawk","year":"2017","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib84","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0196-0644(99)70369-0","article-title":"The hospital emergency department as a social welfare institution","volume":"33","author":"Gordon","year":"1999","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib85","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/acem.12910","article-title":"Emergency department\u2013based opioid harm reduction: moving physicians from willing to doing","volume":"23","author":"Samuels","year":"2016","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib86","series-title":"Preventing HIV Infection Among Injecting Drug Users in High-Risk Countries: An Assessment of the Evidence","year":"2007"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib88","series-title":"Effectiveness of Sterile Needle and Syringe Programming in Reducing HIV\/AIDS Among Injecting Drug Users","year":"2004"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib89","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.annemergmed.2018.08.439","article-title":"A\u00a0quality framework for emergency department treatment of opioid use disorder","volume":"73","author":"Samuels","year":"2019","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib92","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/2046-4053-3-50","article-title":"Effectiveness of brief interventions as part of the screening, brief intervention and referral to treatment (SBIRT) model for reducing the nonmedical use of psychoactive substances: a systematic review","volume":"3","author":"Young","year":"2014","journal-title":"Syst Rev"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib93","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13722-018-0117-1","article-title":"Emergency department screening and interventions for substance use disorders","volume":"13","author":"Hawk","year":"2018","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib95","series-title":"AMA wants new approaches to combat synthetic and injectable drugs","year":"2017"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib98","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12954-018-0276-0","article-title":"Perspectives on rapid fentanyl test strips as a harm reduction practice among young\u00a0adults\u00a0who use drugs: a qualitative study","volume":"16","author":"Goldman","year":"2019","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.annemergmed.2020.11.008_bib99","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugpo.2018.09.009","article-title":"Use of rapid fentanyl test strips among young adults who use drugs","volume":"61","author":"Krieger","year":"2018","journal-title":"Int J Drug Policy"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064420313871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064420313871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:45:15Z","timestamp":1759293915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064420313871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0196064420313871"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2020.11.008","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Between Emergency Department Visits: The Role of Harm Reduction Programs in Mitigating the Harms Associated With Injection Drug Use","name":"articletitle","label":"Article Title"},{"value":"Annals of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annemergmed.2020.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American College of Emergency Physicians.","name":"copyright","label":"Copyright"}]}}